Bata India has announced that for the month ended November 30, 2025, there were no requests received, processed, approved, or rejected concerning the re-lodgement of transfer requests for physical shares under the special window. This information has been submitted to the relevant regulatory body, according to an announcement made on December 24, 2025.

Update on Share Transfer Requests

As of November 30, 2025, Bata India reports on the status of physical share transfer requests. During this reporting period, the company confirms that:

• Requests Received: None
• Requests Processed: None
• Requests Approved: None
• Requests Rejected: None

This update, released on December 24, 2025, reflects the company’s adherence to guidelines concerning the re-lodgement of transfer requests for physical shares under a special window.

Source: BSE

Coforge has launched EvolveOps.AI, a next-generation Agentic AI-powered IT operations management platform designed to empower enterprises for the AI-first era. It leverages hybrid cloud architecture and agentic operations. EvolveOps.AI provides end-to-end autonomous operations across enterprise systems running on hybrid cloud ecosystems. Enterprises using the platform have experienced a 25% reduction in downtime and a 40% reduction in IT operational expenses.

Introducing EvolveOps.AI

Coforge Limited (NSE: COFORGE) has announced the launch of EvolveOps.AI, a next-generation Agentic AI-powered IT operations management platform. The platform helps enterprises prepare for the AI-first era and leverages hybrid cloud architecture and agentic operations for increased agility, resilience and overall transformation. It is powered by advanced Agentic AI agents.

Key Benefits and Features

EvolveOps.AI amplifies and augments enterprise investments in observability, data fabric, and automation platforms to accelerate the journey towards Agentic AI-powered operations. Built using open-source technologies, it facilitates rapid deployment and leverages a large repository of pre-built adaptors and plug-ins, along with a fine-tuned and purpose-built small language model and agentic AI resolver personas. It helps to autonomously administer enterprise IT operations management.

Quantifiable Improvements

Enterprises using EvolveOps.AI have seen significant improvements, including:

• 25% reduction in systems downtime
• 40% reduction in IT operational expenses
• 60% reduction in Mean Time to Detection and Mean Time to Resolution
• 40% faster time to market for products

Mission Zero Approach

Coforge’s strategy for cloud and infrastructure is anchored in Mission Zero – Zero Disruption, Zero Touch, Zero Friction – for every cloud transformation executed. According to Ashish Kumar, Global Business Unit Head – Cloud, AI-Infra, Security & ServiceNow at Coforge, the company is operationalizing that mission by infusing AI agents into every stage of the technology operations lifecycle.

Agentic Personas and Integration

Coforge has developed 28 agentic personas. The platform is designed for seamless integration with the industry’s leading hyperscalers and enterprise IT Operations Management platforms. Its Hybrid Cloud Manager module supports full-stack builds and policy-driven automation across Amazon Web Services (AWS), Microsoft Azure, Google Cloud Platform (GCP), Oracle Cloud Infrastructure (OCI), and private cloud environments.

Source: BSE

Ircon International has issued a statement clarifying its position regarding a recent query from the stock exchange. The company affirms its commitment to disclosing any significant events or information that could impact the company’s share price or trading volume. As of December 24, 2025, Ircon states that there is no undisclosed information related to the company’s operations that would affect its stock performance.

Response to Stock Exchange Query

Ircon International has responded to an email from the stock exchange dated December 24, 2025. The company’s letter, also dated December 24, 2025, addresses queries regarding recent stock activity.

No Undisclosed Information

Ircon International confirms that it is dedicated to keeping the Stock Exchange informed about any significant events, announcements, or information that could influence stock prices or trading volume. The company declared that, as of this announcement, there is no undisclosed information or pending announcements pertaining to the company’s operations that could impact the stock’s behavior.

Commitment to Transparency

Ircon International emphasizes its ongoing commitment to transparency and will continue to promptly disclose any information that may be relevant to shareholders and the market. The company seeks to ensure investors have accurate information regarding events or announcements related to IRCON’s working.

Source: BSE

Alok Industries has issued a clarification regarding recent volume movement. The company states that it has made all necessary disclosures as required under the relevant regulations. Alok Industries also confirms its commitment to complying with all applicable regulations and will continue to make necessary disclosures.

Clarification on Volume Activity

Alok Industries has addressed inquiries regarding recent volume fluctuations. The company asserts it has fulfilled all mandatory disclosure obligations.

Commitment to Compliance

Alok Industries reaffirms its dedication to upholding regulatory standards and ensuring transparent communication. The company confirms its commitment to making all disclosures in compliance.

Source: BSE

HFCL Limited has successfully completed a Qualified Institutions Placement (QIP) of equity shares, issuing and allotting 8,79,29,651 shares at a price of ₹62.55 per share. This includes a premium of ₹61.55 per equity share, raising a total of approximately ₹550 Crores. The QIP was approved on December 24, 2025, following the closure of the issue.

Qualified Institutions Placement Completed

HFCL Limited has announced the successful completion of its qualified institutions placement of equity shares. The Fund Raising Committee of Directors approved the issue and allotment of 8,79,29,651 Equity Shares on December 24, 2025.

Issue Details

The equity shares were issued at a price of ₹62.55 per Equity Share, which includes a premium of ₹61.55 per Equity Share. This resulted in total proceeds of approximately ₹550 Crores for HFCL Limited.

Key Allottees

The following allottees received more than 5% of the Equity Shares offered in the issue:

• Rajasthan Global Securities Private Limited: 1,91,84,652 shares (21.82%)
• NECTA BLOOM VCC – NECTA BLOOM ONE: 1,59,87,210 shares (18.18%)
• FINQUEST FINANCIAL SOLUTIONS PVT. LTD: 1,19,90,407 shares (13.64%)
• SHINE STAR BUILD CAP PVT LTD: 79,93,605 shares (9.09%)
• NOVA GLOBAL OPPORTUNITIES FUND PCC – TOUCHSTONE: 75,13,988 shares (8.55%)
• ABUNDANTIA CAPITAL VCC- ABUNDANTIA CAPITAL III: 63,94,884 shares (7.27%)

Issue Timeline

The issue opened on December 22, 2025, and closed on December 24, 2025. Allottees who have been allotted more than 5% of the Equity Shares offered in the Issue has been listed.

Source: BSE

Rail Vikas Nigam Limited (RVNL) has received a Demand Notice from the Office of the Assistant Commissioner, Range-2, Division-1, Ahmedabad, Gujarat. The notice, in form DRC-07, is dated December 23, 2025, and pertains to the financial year 2021-22. The total demand as per the order is ₹5.56 Crore.

Demand Notice Details

RVNL has received a Demand Notice (DRC-07) from the Assistant Commissioner, Range-2, Division-1, Ahmedabad, Gujarat. The order number is ZD2412251118851 and is dated December 23, 2025, relating to the FY 2021-22.

Financial Impact

The total demand arising from this notice amounts to ₹5.56 Crore. While there is no immediate material impact on the company’s financial operations, RVNL is planning to contest the order.

Action Taken

RVNL has indicated that the order is challengeable and has initiated or will initiate appeals with the appropriate jurisdictional appellate authorities.

Source: BSE

IKS Health has granted 46,000 employee stock options to eligible employees under its Employee Stock Option Plan 2022 (IKS ESOP Plan). This decision, approved on December 24, 2025, aims to incentivize and retain talent. Each option converts into one equity share with a face value of Re. 1. The options are priced at Rs. 1,749.00 per option.

ESOP Grant Details

IKS Health has approved the grant of 46,000 employee stock options to its eligible employees as of December 24, 2025. These options are granted under the company’s Employee Stock Option Plan 2022 (IKS ESOP Plan).

Key Highlights of the ESOP

Here are the notable features of the employee stock options granted:

• Number of Options Granted: 46,000
• Conversion: Each option is convertible into one fully paid-up equity share.
• Face Value: Each equity share has a face value of Re. 1.
• Exercise Price: The options are granted at an exercise price of Rs. 1,749.00 per option.
• Market Price Reference: The exercise price is not less than the market price, specifically the closing price on December 23, 2025, on the National Stock Exchange of India Limited.
• Exercise Period: The stock options can be exercised anytime during continuous active employment from the date of vesting.

Additional Terms

The IKS ESOP Plan is being administered through a Trust. When exercised, each option will be converted into one equity share with a face value of Re.1. The scheme also provides guidelines for handling stock options in various circumstances, including death, permanent incapacity, resignation, and retirement. Adjustments will be made for corporate actions like rights issues and mergers, ensuring fairness under the IKS ESOP Plan. Allotted equity shares are not subject to a lock-in period.

Source: BSE